Meadow Creek Investment Management’s Integra LifeSciences IART Stock Holding History

Meadow Creek Investment Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$811K	Hold	13,496	–	–	0.02%	545
2019 Q2	$754K	Sell	13,496 -420	-3%	-$21.6K	0.02%	570
2019 Q1	$776K	Buy	13,916 +1,792	+15%	+$91.3K	0.02%	542
2018 Q4	$547K	Buy	12,124 +644	+6%	+$35.3K	0.01%	589
2018 Q3	$756K	Buy	11,480 +2,912	+34%	+$181K	0.01%	563
2018 Q2	$552K	Hold	8,568	–	–	0.01%	610
2018 Q1	$474K	Hold	8,568	–	–	0.01%	669
2017 Q4	$410K	Buy	8,568 +1,652	+24%	+$80.9K	0.01%	732
2017 Q3	$349K	Buy	6,916 +1,036	+18%	+$53.2K	0.01%	721
2017 Q2	$320K	Buy	5,880 +1,792	+44%	+$85.6K	0.01%	713
2017 Q1	$172K	Buy	4,088 +392	+11%	+$16.8K	﹤0.01%	774
2016 Q4	$158K	Buy	+3,696	New	+$150K	﹤0.01%	773

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Meadow Creek Investment Management's IART Position: Q3 2019 in Review

Meadow Creek Investment Management held its Integra LifeSciences (IART) position steady in Q3 2019 at 13,496 shares worth $811K. The position accounts for 0.02% of the portfolio, ranked #545.

Meadow Creek Investment Management first reported a position in IART in Q4 2016 and has held it in 12 quarters since. 280 funds tracked by Wall St. Rank hold IART as of Q3 2019.

Meadow Creek Investment Management held 13,496 shares of Integra LifeSciences worth $811K as of Q3 2019.
Meadow Creek Investment Management left its Integra LifeSciences share count unchanged in Q3 2019.
Integra LifeSciences made up 0.02% of Meadow Creek Investment Management's portfolio in Q3 2019, its #545 holding.
Meadow Creek Investment Management first reported a position in Integra LifeSciences in Q4 2016 and has held it in 12 quarters since.
280 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.